Memorial Sloan Kettering Cancer Center - Main

New York, New York 10065

1 studies enrolling now · 3 studies all time

What they study most

Chronic Myeloid Leukemia (for Part B and C), Gastric Cancer, Gastroesophageal Junction Cancer, Healthy (For Part A), Leukemia

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies — Stopped early